Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 18 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BALL | $17.1B | 19.6× | — | 1.3× | 11.6% | — | 7.0% | 16.9% | 16.8% | — | 198 |
| SWK | $15.6B | 39.1× | — | 1.0× | -1.5% | 30.3% | 2.7% | 4.4% | 2.8% | — | 223 |
| MAS | $15.5B | 20.8× | 12.7× | 2.0× | -3.4% | 35.4% | 10.7% | -438% | 29.3% | 1.6× | 240 |
| CCK | $12.8B | 18.5× | 9.4× | 1.0× | 4.8% | — | 6.0% | 24.6% | 8.7% | 2.5× | 156 |
| CR | $11.9B | 32.9× | 26.4× | 5.2× | 8.2% | 42.2% | 15.9% | 17.8% | 11.4% | 1.4× | 153 |
| WTS | $11.7B | 34.5× | 22.8× | 4.8× | 8.3% | 49.5% | 14.0% | 16.8% | 15.3% | -0.4× | 133 |
| VMI | $8.3B | 25.8× | 17.6× | 2.0× | 0.7% | 30.2% | 8.5% | 21.5% | 14.4% | 1.2× | 155 |
| SSD | $8.0B | 23.7× | 14.5× | 3.4× | 4.5% | 45.9% | 14.8% | 17.0% | 14.7% | -0.1× | 99 |
| ACA | $7.3B | 35.2× | 15.3× | 2.5× | 12.2% | 22.4% | 7.2% | 7.9% | 5.0% | 2.3× | 86 |
| MTRN | $5.0B | 67.0× | 30.4× | 2.8× | 6.0% | 17.3% | 4.2% | 7.9% | 5.3% | 2.5× | 85 |
| GEF | $4.7B | — | 13.9× | 1.2× | -9.7% | 22.2% | 21.4% | 28.8% | 20.4% | 2.3× | 59 |
| GFF | $4.7B | 94.4× | — | 1.9× | -3.9% | 42.0% | 2.0% | 69.1% | 3.4% | — | 68 |
| SLGN | $4.2B | 14.6× | — | 0.6× | 10.7% | 17.7% | 4.4% | 12.7% | 4.4% | — | 70 |
| AZZ | $4.1B | 13.1× | 13.0× | 2.5× | 4.6% | 23.9% | 19.2% | 23.7% | 17.5% | 1.3× | 70 |
| MWA | $3.6B | 18.7× | 13.0× | 2.5× | 8.7% | 36.1% | 13.4% | 19.5% | 13.4% | 1.5× | 77 |
| CXT | $3.5B | 24.1× | 12.4× | 2.1× | 11.4% | 42.5% | 8.8% | 11.6% | 6.1% | 2.6× | 76 |
| HLIO | $2.3B | 47.1× | 18.9× | 2.7× | 4.1% | 32.3% | 5.8% | 5.2% | 4.1% | 1.5× | 37 |
| PRLB | $1.9B | 88.2× | 29.6× | 3.5× | 6.4% | 44.5% | 4.0% | 3.2% | 3.2% | -1.9× | 54 |
| HLMN | $1.5B | 39.0× | 8.5× | 1.0× | 5.4% | — | 2.6% | 3.3% | 2.1% | 2.6× | 43 |
Peers = companies sharing MTRN's sector (Metal Forgings & Stampings) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $221.94 today, the market must believe free cash flow compounds 39.1%/yr for a decade (off $34.3M on the 3-yr avg basis).
On the basis ($23.8M) the requirement is 44.7%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 39.1% is more optimistic than its 9-yr track record.
Default is 11.4% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.02B shares (market data) · net debt $445.1M
mean -1.7% · volatility σ 87% · implied rate exceeded in 2/8 yrs
Central path = implied 39.1%/yr growth; shaded band = ±1σ (87%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 23% of free cash flow, leaving room to grow it and fund buybacks. Last year: $11.5M dividends + $7.8M buybacks = $19.4M returned on $50.0M FCF.
9 consecutive years of dividend increases · 4%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 5%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $13.7M is below the $22.4M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~6.7% on $458.8M of debt.
Cash of $13.7M is below short-term debt of $22.4M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.79B 100.0% | $1.68B 100.0% | $1.67B 100.0% | $1.76B 100.0% | $1.51B 100.0% | $1.18B 100.0% | $1.19B 100.0% | $1.21B 100.0% | $1.14B 100.0% | $969.2M 100.0% |
| Cost of Revenue | $1.48B 82.7% | $1.36B 80.7% | $1.32B 79.0% | $1.41B 80.4% | $1.23B 81.2% | $983.6M 83.6% | $922.7M 77.8% | $956.5M 79.2% | $926.6M 81.3% | $784.7M 81.0% |
| Cost of Products | — | — | — | — | — | — | — | — | $928.0M 81.4% | $785.8M 81.1% |
| Gross Profit | $308.6M 17.3% | $326.0M 19.3% | $349.0M 21.0% | $343.9M 19.6% | $283.8M 18.8% | $192.6M 16.4% | $262.7M 22.2% | $251.4M 20.8% | $212.8M 18.7% | $184.5M 19.0% |
| Research & Development | $25.9M 1.5% | $29.0M 1.7% | $27.5M 1.7% | $29.0M 1.6% | $26.6M 1.8% | $20.3M 1.7% | $18.3M 1.5% | $15.2M 1.3% | $14.0M 1.2% | $12.8M 1.3% |
| Selling, General & Admin | $143.1M 8.0% | $145.6M 8.6% | $157.9M 9.5% | $169.3M 9.6% | $163.8M 10.8% | $134.0M 11.4% | $147.2M 12.4% | $153.5M 12.7% | $144.3M 12.7% | $129.0M 13.3% |
| Operating Income | $109.8M 6.1% | $47.2M 2.8% | $136.4M 8.2% | $119.8M 6.8% | $77.1M 5.1% | $8.2M 0.7% | $70.5M 6.0% | $61.8M 5.1% | $40.0M 3.5% | $28.9M 3.0% |
| Interest Expense | $30.7M 1.7% | $34.8M 2.1% | $31.3M 1.9% | $21.9M 1.2% | — | — | — | — | — | — |
| Other Income (Expense), net | $2.4M 0.1% | $2.4M 0.1% | $2.7M 0.2% | $5.3M 0.3% | $5.1M 0.3% | $3.9M 0.3% | -$3.4M -0.3% | -$42.7M -3.5% | -$1.5M -0.1% | -$1.8M -0.2% |
| Pretax Income | $81.5M 4.6% | $14.9M 0.9% | $107.8M 6.5% | $103.1M 5.9% | $77.3M 5.1% | $8.3M 0.7% | $65.5M 5.5% | $16.6M 1.4% | $36.4M 3.2% | $25.3M 2.6% |
| Income Tax Expense | $6.7M 0.4% | $9.0M 0.5% | $12.1M 0.7% | $17.1M 1.0% | $4.9M 0.3% | -$7.2M -0.6% | $12.1M 1.0% | -$4.4M -0.4% | $24.9M 2.2% | -$425K -0.0% |
| Net Income | $74.8M 4.2% | $5.9M 0.3% | $95.7M 5.7% | $86.0M 4.9% | $72.5M 4.8% | $15.5M 1.3% | $53.4M 4.5% | $21.0M 1.7% | $11.5M 1.0% | $25.7M 2.7% |
| Per Share | ||||||||||
| EPS (Basic) | $3.61 | $0.28 | $4.64 | $4.19 | $3.55 | $0.76 | $2.62 | $1.04 | $0.57 | $1.29 |
| EPS (Diluted) | $3.58 | $0.28 | $4.58 | $4.14 | $3.50 | $0.75 | $2.59 | $1.02 | $0.56 | $1.27 |
| Weighted Avg Shares (Basic) | 20.8M | 20.7M | 20.6M | 20.5M | 20.4M | 20.3M | 20.4M | 20.2M | 20.0M | 20.0M |
| Weighted Avg Shares (Diluted) | 20.9M | 20.9M | 20.9M | 20.8M | 20.7M | 20.6M | 20.7M | 20.6M | 20.4M | 20.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 95th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 8% against ROIC 5% — 3% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 21.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 79.2 | 77.8 | 83.6 | 81.2 | 80.4 | 79.0 | 80.7 | 82.7 |
| Gross Profit | 20.8 | 22.2 | 16.4 | 18.8 | 19.6 | 21.0 | 19.3 | 17.3 |
| R&D | 1.3 | 1.5 | 1.7 | 1.8 | 1.6 | 1.7 | 1.7 | 1.5 |
| SG&A | 12.7 | 12.4 | 11.4 | 10.8 | 9.6 | 9.5 | 8.6 | 8.0 |
| Operating Income | 5.1 | 6.0 | 0.7 | 5.1 | 6.8 | 8.2 | 2.8 | 6.1 |
| Income Tax | -0.4 | 1.0 | -0.6 | 0.3 | 1.0 | 0.7 | 0.5 | 0.4 |
| Net Income | 1.7 | 4.5 | 1.3 | 4.8 | 4.9 | 5.7 | 0.3 | 4.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MTRN: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Earns -5.93pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 8.8% | 11.4% (today's — no rate published for this year) | -2.6pts |
| FY2020 | 0.8% | 11.4% (today's — no rate published for this year) | -10.6pts |
| FY2021 | 4.5% | 11.4% (today's — no rate published for this year) | -6.9pts |
| FY2022 | 6.7% | 8.3% | -1.6pts |
| FY2023 | 7.2% | 9.0% | -1.8pts |
| FY2024 | 2.5% | 11.6% | -9.1pts |
| FY2025 | 5.4% | 9.5% | -4.0pts |
| Now | 5.3% | 11.4% | -6.0pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 19.0% | 3.0% | 2.7% |
| FY2017 | 18.7% | 3.5% | 1.0% |
| FY2018 | 20.8% | 5.1% | 1.7% |
| FY2019 | 22.2% | 6.0% | 4.5% |
| FY2020 | 16.4% | 0.7% | 1.3% |
| FY2021 | 18.8% | 5.1% | 4.8% |
| FY2022 | 19.6% | 6.8% | 4.9% |
| FY2023 | 21.0% | 8.2% | 5.7% |
| FY2024 | 19.3% | 2.8% | 0.3% |
| FY2025 | 17.3% | 6.1% | 4.2% |
Leverage and buybacks account for 3 points of the 8% return on equity in FY2025. The business earns 5% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$280M of goodwill — 19% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
Margins have compressed 2 years running even as the spread stayed positive.
Converts 0.91x of reported profit into free cash flow over 5 years, with accruals negative.
Reported free cash flow is $50M; after share-based compensation it is $39M. The difference is a real cost that the cash flow statement adds back.
Covers interest 2.5x under stress — adequate, without much room.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 3.58x |
| 5% | 3.40x |
| 10% | 3.22x |
| 15% | 3.04x |
| 20% | 2.86x |
| 25% | 2.68x |
| 30% | 2.50x |
| 35% | 2.33x |
| 40% | 2.15x |
| 45% | 1.97x |
| 50% | 1.79x |
| 55% | 1.61x |
| 60% | 1.43x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $239.81, free cash flow must compound 40.36%/yr for 10 years. It has done -6.54%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −54.9% | 40.4% |
| FY2021 | −137.5% | 40.4% |
| FY2023 | −11.7% | 40.4% |
| FY2024 | −43.4% | 40.4% |
| FY2025 | 160.7% | 40.4% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 1 of the last 5 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $75M | $75M |
| Share-based comp | $11M | $86M |
| Other non-cash & working capital | $17M | $103M |
| Operating cash flow | $103M | $103M |
| Capex | −$53M | $50M |
| Free cash flow | $50M | $50M |
| FCF after SBC | $39M | $39M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -0.8% | 7.6% | 8.3 points |
| FY2021 | 28.4% | 28.5% | 0.0 points |
| FY2022 | 16.3% | 0.7% | -15.7 points |
| FY2023 | -5.2% | -10.4% | -5.2 points |
| FY2024 | 1.2% | 0.5% | -0.6 points |
| FY2025 | 6.0% | 15.0% | 9.0 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 47.6 days | 93.5 days | 17.1 days | 124 days |
| FY2020 | 51.6 days | 93.1 days | 20.6 days | 124.1 days |
| FY2021 | 51.7 days | 107.4 days | 25.7 days | 133.4 days |
| FY2022 | 44.7 days | 109.3 days | 27.9 days | 126.1 days |
| FY2023 | 42.2 days | 122.5 days | 34.8 days | 129.9 days |
| FY2024 | 42 days | 118.5 days | 28.4 days | 132.1 days |
| FY2025 | 45.5 days | 113.9 days | 36.7 days | 122.7 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -5.1 percent |
| FY2020 | -8.1 percent |
| FY2021 | -1.1 percent |
| FY2022 | -1.8 percent |
| FY2023 | -2.8 percent |
| FY2024 | -4.8 percent |
| FY2025 | -1.6 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 2 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-14 | Prevost Patrick M. Director | Grantindirect | 75 | $271.84 | $20k |
| 2026-10-14 | Shular Craig S Director | Grantindirect | 89 | $271.84 | $24k |
| 2026-09-04 | Chadwick Shelly Marie Vice President, Finance & CFO | Grant | 8 | $0.00 | — |
| 2026-09-04 | Vijayvargiya Jugal K. President and CEO | Grant | 11 | $0.00 | — |
| 2026-09-04 | Chemnitz Gregory R. VP General Counsel & Secretary | Grant | 2 | $0.00 | — |
| 2026-09-04 | Prevost Patrick M. Director | Grantindirect | 10 | $0.00 | $0 |
| 2026-09-04 | Liggett Emily M Director | Grantindirect | 1 | $0.00 | $0 |
| 2026-09-04 | Phillippy Robert J Director | Grantindirect | 7 | $0.00 | $0 |
| 2026-09-04 | Shular Craig S Director | Grantindirect | 31 | $0.00 | $0 |
| 2026-09-04 | Khilnani Vinod M Director | Grantindirect | 12 | $0.00 | $0 |
| 2026-09-04 | Fashinpaur Melissa A Chief Accounting Officer | Grant | 1 | $0.00 | — |
| 2026-09-01 | Liggett Emily M Director | Open-market sale | 1,012 | $232.42 | $235k |
| 2026-08-31 | Khilnani Vinod M Director | Open-market sale | 2,000 | $235.16 | $470k |
| 2026-08-31 | 2 co-filers Group filing | Giftindirect | 28,832 | $0.00 | $0 |
| 2026-08-31 | 2 co-filers Group filing | Giftindirect | 28,832 | $0.00 | $0 |
| 2026-08-21 | Liggett Emily M Director | Gift | 1,609 | $0.00 | $0 |
| 2026-08-10 | 2 co-filers Group filing | Gift | 28,832 | $0.00 | $0 |
| 2026-08-10 | 2 co-filers Group filing | Giftindirect | 28,832 | $0.00 | $0 |
| 2026-08-07 | Solomon Darlene J. S. Director | Open-market sale | 3,705 | $292.22 | $1.1m |
| 2026-08-07 | 6 co-filers Vice President, Finance & CFO | Option exercise | 2,800 | $135.58 | $380k |
| 2026-08-07 | 11 co-filers President and CEO | Option exercise | 24,594 | $68.82 | $1.7m |
| 2026-08-07 | 6 co-filers Vice President, Finance & CFO | Option exercise | 2,172 | $87.36 | $190k |
| 2026-08-07 | 11 co-filers President and CEO | Tax withholding | 13,146 | $296.00 | $3.9m |
| 2026-08-07 | 6 co-filers Vice President, Finance & CFO | Tax withholding | 3,267 | $293.40 | $959k |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 1,375 | $287.67 | $396k |
| 2026-08-07 | 6 co-filers Vice President, Finance & CFO | Exercise & sell | 1,705 | $293.00 | $500k |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 287 | $288.29 | $83k |
| 2026-08-07 | 6 co-filers Vice President, Finance & CFO | Option exercise | 2,800 | $0.00 | — |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 11,174 | $290.12 | $3.2m |
| 2026-08-07 | 6 co-filers Vice President, Finance & CFO | Option exercise | 2,172 | $0.00 | — |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 3,745 | $292.46 | $1.1m |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 2,337 | $293.64 | $686k |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 4,865 | $294.45 | $1.4m |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 286 | $295.17 | $84k |
| 2026-08-07 | 11 co-filers President and CEO | Exercise & sell | 267 | $293.24 | $78k |
| 2026-08-07 | 11 co-filers President and CEO | Option exercise | 24,594 | $0.00 | — |
| 2026-07-15 | Prevost Patrick M. Director | Grantindirect | 81 | $253.27 | $21k |
| 2026-07-15 | Shular Craig S Director | Grantindirect | 96 | $253.27 | $24k |
| 2026-06-12 | Khilnani Vinod M Director | Grantindirect | 12 | $0.00 | $0 |
| 2026-06-12 | Fashinpaur Melissa A Chief Accounting Officer | Grant | 1 | $0.00 | — |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.